Protein-bound toxins - Update 2009

Seminars in Dialysis

Volumn 22, Issue 4, 2009, Pages 334-339

  Jourde Chiche, Noémie ^a   Dou, Laetitia ^a   Cerini, Claire ^a   Dignat George, Françoise ^a   Vanholder, Raymond ^b   Brunet, Philippe ^a,c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIN;

ARTICLE; HUMAN; KIDNEY DISEASE; PHYSIOLOGY; PROTEIN BINDING; RENAL REPLACEMENT THERAPY;

HUMANS; KIDNEY DISEASES; PROTEIN BINDING; RENAL DIALYSIS; TOXINS, BIOLOGICAL;

EID: 69249098848     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00576.x     Document Type: Article

References (49)

1. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W, European Uremic Toxin Work Group (EUTox) : Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63 : 1934 1943, 2003
2. Vanholder R, Van Laecke S, Glorieux G : What is new in uremic toxicity? Pediatr Nephrol 23 : 1211 1221, 2008
3. Vanholder R, De Smet R, Lameire N : Protein-bound uremic solutes: the forgotten toxins. Kidney Int Suppl 78 : S266 S270, 2001
4. Brunet P, Dou L, Cerini C, Berland Y : Protein-bound uremic retention solutes. Adv Ren Replace Ther 10 : 310 320, 2003
5. Martinez AW, Recht NS, Hostetter TH, Meyer TW : Removal of P-cresol sulfate by hemodialysis. J Am Soc Nephrol 16 : 3430 3436, 2005
6. Schepers E, Meert N, Glorieux G, Goeman J, Van der Eycken J, Vanholder R : P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 22 : 592 596, 2007
7. Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P : Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73 : 1174 1180, 2008
8. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y : Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69 : 1081 1087, 2006
9. Jankowski J, Luftmann H, Tepel M, Leibfritz D, Zidek W, Schlüter H : Characterization of dimethylguanosine, phenylethylamine, and phenylacetic acid asinhibitors of Ca2+ ATPase in end-stage renal failure. J Am Soc Nephrol 9 : 1249 1257, 1998
10. Jankowski J, van der Giet M, Jankowski V, Schmidt S, Hemeier M, Mahn B, Giebing G, Tolle M, Luftmann H, Schluter H, Zidek W, Tepel M : Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest 112 : 256 264, 2003
11. Schmidt S, Westhoff TH, Krauser P, Ignatius R, Jankowski J, Jankowski V, Zidek W, van der Giet M : The uraemic toxin phenylacetic acid impairs macrophage function. Nephrol Dial Transplant 23 : 3485 3493, 2008
12. Schmidt S, Westhoff TH, Krauser P, Zidek W, van der Giet M : The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells. Nephrol Dial Transplant 23 : 65 71, 2008
13. Yano S, Yamaguchi T, Kanazawa I, Ogawa N, Hayashi K, Yamauchi M, Sugimoto T : The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure. Nephrol Dial Transplant 22 : 3160 3165, 2007
14. McGregor D : Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties. Crit Rev Toxicol 37 : 887 914, 2007
15. Igarashi K, Ueda S, Yoshida K, Kashiwagi K : Polyamines in renal failure. Amino Acids 31 : 477 483, 2006
16. Yoshida K, Yoneda T, Kimura S, Fujimoto K, Okajima E, Hirao Y : Polyamines as an inhibitor on erythropoiesis of hemodialysis patients by in vitro bioassay using the fetal mouse liver assay. Ther Apher Dial 10 : 267 272, 2006
17. Myung CS, Blankenship JW, Meerdink DJ : A mechanism of vasodilatory action of polyamines and acetylpolyamines: possible involvement of their Ca2+ antagonistic properties. J Pharm Pharmacol 52 : 695 707, 2000
18. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P : The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 65 : 442 451, 2004
19. Galli F, Beninati S, Benedetti S, Lentini A, Canestrari F, Tabilio A, Buoncristiani U : Polymeric protein-polyamine conjugates: a new class of uremic toxins affecting erythropoiesis. Kidney Int Suppl 78 : S73 S76, 2001
20. Pawlak D, Tankiewicz A, Buczko W : Kynurenine and its metabolites in the rat with experimental renal insufficiency. J Physiol Pharmacol 54 : 175 189, 2003
21. Smith AJ, Stone TW, Smith RA : Neurotoxicity of tryptophan metabolites. Biochem Soc Trans 35 : 1287 1289, 2007
22. Schuck PF, Tonin A, da Costa Ferreira G, Viegas CM, Latini A, Duval Wannmacher CM, de Souza Wyse AT, Dutra-Filho CS, Wajner M : Kynurenines impair energy metabolism in rat cerebral cortex. Cell Mol Neurobiol 27 : 147 160, 2007
23. Karasek M, Szuflet A, Chrzanowski W, Zylinska K, Swietoslawski J : Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuro Endocrinol Lett 26 : 653 656, 2005
24. Lüdemann P, Zwernemann S, Lerchl A : Clearance of melatonin and 6-sulfatoxymelatonin by hemodialysis in patients with end-stage renal disease. J Pineal Res 31 : 222 227, 2001
25. Viljoen M, Steyn ME, van Rensburg BW, Reinach SG : Melatonin in chronic renal failure. Nephron 60 : 138 143, 1992
26. Kancheva R, Sulková S, Svára F, Hill M, Kanchev L, Zofková I : Increase of nocturnal melatonin levels in hemodialyzed patients after parathyroidectomy: a pilot study. Physiol Res 57 (Suppl 1 S181 S185, 2008
27. Raff AC, Meyer TW, Hostetter TH : New insights into uremic toxicity. Curr Opin Nephrol Hypertens 17 : 560 565, 2008
28. Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T : Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant 23 : 1892 1901, 2008
29. Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F, Brunet P : The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost 5 : 1302 1308, 2007
30. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F : Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 4 : 566 573, 2006
31. Motojima M, Hosokawa A, Yamato H, Muraki T, Yoshioka T : Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells. Kidney Int 63 : 1671 1680, 2003
32. Ueda H, Shibahara N, Takagi S, Inoue T, Katsuoka Y : AST-120 treatment in pre-dialysis period affects the prognosis in patients on hemodialysis. Ren Fail 30 : 856 860, 2008
33. Satoh M, Hayashi H, Watanabe M, Ueda K, Yamato H, Yoshioka T, Motojima M : Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure. Nephron Exp Nephrol 95 : e111 e118, 2003
34. Cohen G, Hörl WH : Retinol binding protein isolated from acute renal failure patients inhibits polymorphonuclear leucocyte functions. Eur J Clin Invest 34 : 774 781, 2004
35. Cohen G, Raupachova J, Wimmer T, Deicher R, Hörl WH : The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients. Nephrol Dial Transplant 23 : 2512 2519, 2008
36. Carrero JJ, Park S-H, Axelsson J, Lindholm B, Stenvinkel P : Cytokines, atherogenesis, and hypercatabolism in chronic kidney disease: a dreadful triad. Semin Dial 22 : 381 386, 2009
37. Perna AF, Ingrosso D, Violetti E, Grazia Luciano M, Sepe I, Lanza D, Capasso R, Ascione E, Raiola I, Lombardi C, Stenvinkel P, Massy Z, De Santo NG : Hyperhomocysteinemia in uremia - a red flag in a disrupted circuit. Semin Dial 22 : 351 356, 2009
38. Thornalley PJ, Rabbani N : Highlights and hotspots of protein glycation in end-stage renal disease. Semin Dial 22 : 400 404, 2009
39. Meijers BK, Bammens B, Verbeke K, Evenepoel P : A review of albumin binding in CKD. Am J Kidney Dis 51 : 839 850, 2008
40. Thornalley PJ, Argirova M, Ahmed N, Mann VM, Argirov O, Dawnay A : Mass spectrometric monitoring of albumin in uremia. Kidney Int 58 : 2228 2234, 2000
41. Fasano M, Curry S, Terreno E, Galliano M, Fanali G, Narciso P, Notari S, Ascenzi P : The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57 : 787 796, 2005 (Pubitemid 43062399)
42. Lesaffer G, De Smet R, Lameire N, Dhondt A, Duym P, Vanholder R : Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. Nephrol Dial Transplant 15 : 50 57, 2000
43. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y : Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study. Am J Kidney Dis 44 : 278 285, 2004
44. Meert N, Eloot S, Waterloos MA, Van Landschoot M, Dhondt A, Glorieux G, Ledebo I, Vanholder R : Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 24 : 562 570, 2009
45. Meyer TW, Peattie JW, Miller JD, Dinh DC, Recht NS, Walther JL, Hostetter TH : Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol 18 : 868 874, 2007
46. Wernert V, Schaf O, Faure V, Brunet P, Dou L, Berland Y, Boulet P, Kuchta B, Denoyel R : Adsorption of the uremic toxin p-cresol onto hemodialysis membranes and microporous adsorbent zeolite silicalite. J Biotechnol 123 : 164 173, 2006
47. Krieter DH, Canaud B : High permeability of dialysis membranes: what is the limit of albumin loss? Nephrol Dial Transplant 18 : 651 654, 2003
48. Evenepoel P, Bammens B, Verbeke K, Vanrenterghem Y : Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis. Kidney Int 70 : 794 799, 2006
49. Vanholder R, Meert N, Biesen WV, Meyer T, Hostetter T, Dhondt A, Eloot S. Why do patients on peritoneal dialysis have low serum levels of protein-bound solutes? Nat Clin Pract Nephrol 5 : 130 131, 2009